BGI Genomics Launches Spearheading Innovation in Uruguay

BGI Genomics Launches Spearheading Innovation in Uruguay

By, Admin 23 April 2024

BGI Genomics Launches First Clinical Laboratory in Uruguay, Spearheading Innovation

Overview

BGI Genomics, a renowned leader in precision medicine solutions, has launched a cutting-edge clinical laboratory in Uruguay's Parque de las Ciencias free trade zone. This move is poised to advance preventive healthcare throughout Latin America, employing state-of-the-art technology for early disease detection.

Figures Present at the Ceremony

  • The opening ceremony saw the presence of notable figures including Omar Paganini, Minister of Foreign Affairs; Elisa Facio, Minister of Industry, Energy, and Mining; and Karina Rando, Minister of Public Health, alongside other national and departmental dignitaries. 
  • Dr. Yin Ye, CEO of BGI Group, the parent company of BGI Genomics, also attended. 
  • Minister Rando had previously visited the site in August 2023, and Minister Facio had met with Dr. Yin Ye in China in November 2023.

BGI Genomics Library

  • This groundbreaking laboratory, spanning 1,000 square meters, is solely dedicated to BGI Genomics' operations, specializing in precision medicine applications. 
  • It features a Huo-Yan Air Laboratory equipped with seven cabins, covering the entire genetic testing process. 
  • Notable features include an advanced HVAC system and design elements to prevent contamination between cabins.

Current Workforce

The current workforce comprises Uruguayan technicians specializing in biochemistry and biotechnology, supplemented by application experts from China who provide training on the latest technologies.

Key Achievement

A key achievement of BGI Genomics is the development of Next-Generation Sequencing (NGS) technology, aimed at enhancing accessibility and affordability of genetic testing across Latin America.

Key Persons on the The Laboratory

  • Elisa Facio, Minister of Industry, Energy, and Mining, expressed excitement about Uruguay's potential in the biotechnology sector, with the launch of BGI Genomics' laboratory being a significant step forward.
  • Natalia Pereiras, laboratory director, highlighted the goal of making advanced diagnostic tools accessible at an affordable cost, achieved through in-house product and methodology development.
  • Wu Liang, general manager for Latin America at BGI Genomics, emphasized Uruguay's strategic advantages, leveraging its proximity to Carrasco Airport and the benefits of operating within a free trade zone.

Oncology Portfolio

BGI Genomics' extensive oncology portfolio includes COLOTECT, a Real-Time PCR-based product for detecting colorectal cancer. Additionally, the SENTIS portfolio aids clinicians in selecting optimal treatments for cancer patients.

Other Areas of Focus

  • Reproductive health is another focus area, with products like NIFTY offering prenatal screening from the tenth week of gestation, providing crucial insights into chromosomal abnormalities and disorders. 
  • NIFTY Pro enhances screening capabilities, detecting a broader range of conditions including DiGeorge syndrome.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!